Tranexamic acid for spontaneous intracerebral hemorrhage: A randomized controlled pilot trial (ISRCTN50867461)

Journal of Stroke and Cerebrovascular Diseases

Volumn 23, Issue 6, 2014, Pages 1312-1318

  Sprigg, Nikola ^a   Renton, Cheryl J ^a   Dineen, Robert A ^a   Kwong, Yune ^b   Bath, Philip M W ^a  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^b NOTTINGHAM UNIVERSITY HOSPITALS NHS TRUST   (United Kingdom)

Author keywords

Acute stroke; intracerebral hemorrhage; randomized controlled trials; tranexamic acid

Indexed keywords

PLACEBO; TRANEXAMIC ACID; ANTIFIBRINOLYTIC AGENT;

AGED; ARTICLE; BOLUS INJECTION; BRAIN HEMORRHAGE; CLINICAL ARTICLE; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; DRUG DEPENDENCE; DRUG FATALITY; DRUG HYPERSENSITIVITY; DRUG SAFETY; DRUG TOLERABILITY; FEASIBILITY STUDY; FEMALE; HEMATOMA; HUMAN; MALE; PILOT STUDY; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; CEREBRAL HEMORRHAGE; CLINICAL TRIAL; DOUBLE BLIND PROCEDURE; MIDDLE AGED; PHASE 2 CLINICAL TRIAL; TREATMENT OUTCOME; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ANTIFIBRINOLYTIC AGENTS; CEREBRAL HEMORRHAGE; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MALE; MIDDLE AGED; PILOT PROJECTS; PROSPECTIVE STUDIES; TRANEXAMIC ACID; TREATMENT OUTCOME;

EID: 84902536066     PISSN: 10523057     EISSN: 15328511     Source Type: Journal    
DOI: 10.1016/j.jstrokecerebrovasdis.2013.11.007     Document Type: Article

References (37)

1. T. Steiner, and J. Bosel Options to restrict hematoma expansion after spontaneous intracerebral hemorrhage Stroke 41 2010 402 409
2. J.E. Delgado Almandoz, A.J. Yoo, and M.J. Stone et al. Systematic characterization of the computed tomography angiography spot sign in primary intracerebral hemorrhage identifies patients at highest risk for hematoma expansion Stroke 40 2009 2994 3000
3. J.E. Delgado Almandoz, A.J. Yoo, and M.J. Stone et al. The spot sign score in primary intracerebral hemorrhage identifies patients at highest risk of in-hospital mortality and poor outcome among survivors Stroke 41 2010 54 60
4. A. Ederies, A. Demchuk, and T. Chia et al. Postcontrast CT extravasation is associated with hematoma expansion in CTA spot negative patients Stroke 40 2009 1672 1676
5. M. Andrew, D.D. Demchuk, D. Rodriguez-Luna PREDICT/Sunnybrook ICH CTA Study Group Prediction of haematoma growth and outcome in patients with intracerebral haemorrhage using the CT-angiography spot sign (PREDICT): a prospective observational study Lancet Neurol 11 2012 307 314
6. A.D. Mendelow, B.A. Gregson, and H.M. Fernades et al. Early surgery versus initial conservative treatment in patients with spontaneour supratentorial intracerebral haematomas in the International Surgical Trial in Intracerebral Haemorrhage (STICH): a randomised trial Lancet 365 2005 387 397
7. A.D. Mendelow, B.A. Gregson, E.N. Rowan STICH II Investigators Early surgery versus initial conservative treatment in patients with spontaneous supratentorial lobar intracerebral haematomas (STICH II): a randomised trial Lancet 382 2013 397 408
8. C.S. Anderson, Y. Huang, and J.G. Wang et al. Intensive blood pressure reduction in acute cerebral haemorrhage trial (INTERACT): a randomised pilot trial Lancet Neurol 7 2008 391 399
9. C.S. Anderson, E. Heeley, Y. Huang INTERACT2 Investigators Rapid blood-pressure lowering in patients with acute intracerebral hemorrhage N Engl J Med 368 2013 2355 2365
10. S.A. Mayer, N.C. Brun, and K. Begtrup et al. Recombinant activated factor VII for acute intracerebral hemorrhage N Engl J Med 352 2005 777 785
11. S.A. Mayer, N.C. Brun, and K. Begtrup et al. Efficacy and safety of recombinant activated factor VII for acute intracerebral hemorrhage N Engl J Med 358 2008 2127 2137
12. R. Al-Shahi Salman Haemostatic drug therapies for acute spontaneous intracerebral haemorrhage Cochrane Database Syst Rev 4 2009, Oct 7 CD005951
13. C.J. Creutzfeldt, J.R. Weinstein, and W.T. Longstreth Jr. et al. Prior antiplatelet therapy, platelet infusion therapy, and outcome after intracerebral hemorrhage J Stroke Cerebrovasc Dis 18 2009 22108
14. Al-Shahi Salman R. Platelet transfusion in cerebral haemorrhage. 2012. Available at: http://public.ukcrn.org.uk/search/StudyDetail.aspx?StudyID=9030. Accessed November 2013.
15. C.J. Dunn, and K.L. Goa Tranexamic acid: a review of its use in surgery and other indications Drugs 57 1999 1005 1032
16. I. Roberts, H. Shakur, K. Ker CRASH-2 Trial collaborators Antifibrinolytic drugs for acute traumatic injury Cochrane Database Syst Rev 2011 (1); CD004896
17. CRASH-2 Trial Collaborators Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial Lancet 17 2010 1 79
18. The CRASH-2 Collaborators The importance of early treatment with tranexamic acid in bleeding trauma patients: an exploratory analysis of the CRASH-2 randomised controlled trial Lancet 377 2011 1096 1101
19. CRASH-2 Collaborators (Intracranial Bleeding Study) Effect of tranexamic acid in traumatic brain injury: a nested randomised, placebo controlled trial (CRASH-2 Intracranial Bleeding Study) BMJ 343 2011 d3795
20. Y. Surakrant, P.P. Warawut K, and T. Bandit et al. Tranexamic acid for preventing progressive intracranial hemorrage in adults with traumatic brain injury [abstract] Natl Neurotrauma Symposium, Las Vegas, NV, June 16 2010
21. Yvo Roos GR, Vermeulen M, Algra A, et al. Antifibrinolytic therapy for aneurysmal subarachnoid hemorrhage: a major update of a cochrane review stroke. 2003;34:2308-2309.
22. J. Hillman, S. Fridriksson, and O. Nilsson et al. Immediate administration of tranexamic acid and reduced incidence of early rebleeding after aneurysmal subarachnoid hemorrhage: a prospective randomized study J Neurosurg 97 2002 771 778
23. M.R. Germans, R. Post, and B.A. Coert et al. Ultra-early tranexamic acid after subarachnoid hemorrhage (ULTRA): study protocol for a randomized controlled trial Trials 16 2013 143
24. M.F. Ojacastro, R.P. Tabuena, and M.P. Tabuena et al. Efficacy of tranexamic acid in reducing hematoma volume in patients with hypertensive intracerebral hemorrhage Int J Stroke 3 Suppl 1 2008 197 198
25. T. Sorimachi, Y. Fujii, and K. Morita et al. Rapid administration of antifibrinolytics and strict blood pressure control for intracerebral hemorrhage Neurosurgery 57 2005 837 844
26. Y. Roos Editorial: tranexamic acid for traumatic brain injury BMJ 343 2011 d3958
27. K. Bridget, B.K. Fiechtner, G.A.N. Nuttall, and M.E. Johnson et al. Plasma tranexamic acid concentrations during cardiopulmonary bypass Anesthesia Anesthesiol 92 2001 1131 1136
28. D. Dowlatshahi, A.M. Demchuk, M.L. Flaherty VISTA Collaboration Defining hematoma expansion in intracerebral hemorrhage: relationship with patient outcomes Neurology 76 2011 1238 1244
29. Fedorov A, Beichel R, Kalpathy-Cramer J, et al. 3D Slicer as an image computing platform for the Quantitative Imaging Network. Magn Reson Imaging.30:1323-1341.
30. R.D. Zimmerman, J.A. Maldjian, and N.C. Brun et al. Radiologic estimation of hematoma volume in intracerebral hemorrhage trial by CT scan Am J Neuroradiol 27 2006 666 670
31. P. Saloheimo, M. Ahonen, and S. Juvela et al. Regular aspirin-use preceding the onset of primary intracerebral hemorrhage is an independent predictor for death Stroke 37 2006 129 133
32. J.M. Wardlaw Prediction of haematoma expansion with the CTA spot sign: a useful biomarker? Lancet Neurol 11 2012 294 295
33. S. Illanes, W. Zhou, and S. Schwarting et al. Comparative effectiveness of hemostatic therapy in experimental warfarin-associated intracerebral hemorrhage Stroke 42 2011 191 195
34. T. Brott, J. Broderick, and R. Kothari et al. Early hemorrhage growth in patients with intracerebral hemorrhage Stroke 28 1997 1 5
35. National Institute of Neurological Disorders and Stroke rt-PA Study Group Tissue plasminogen activator for acute ischaemic stroke N Engl J Med 333 1995 1581 1587
36. Davis, SM, Donnan GM. Tranexamic acid for intracerebral haemorrhage TICH-2. 2013. Available at: http://www.controlled-trials.com/ISRCTN93732214/. Accessed March 31, 2013.
37. STOP-AUST: the spot sign and tranexamic acid on preventing ICH growth - AUStralasia trial. 2013. Available at: http://clinicaltrials.gov/show/ NCT01702636. Accessed August 8.